Loading…
CIK 0001958125 • 7 13F filings • May 15, 2025 – Sep 2, 2026
Import this data to Google Sheets with:
=jivedata("catalio-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES COR | COM | $16.3M | 3.4%Prev: 2.1% | 1,396,445 SH | Increased+673,661 SH |
| ADMA BIOLOGICS INC | COM | $10.4M | 2.2% | 569,704 SH | New |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $31.1M | 6.5%Prev: 6.2% | 179,926 SH | Increased+50,815 SH |
| ATAI LIFE SCIENCES NV | SHS | $431K | 0.1% | 196,858 SH | New |
| BICARA THERAPEUTICS INC | COM | $909K | 0.2% | 97,800 SH | New |
| BOSTON SCIENTIFIC CORP | COM | $24.6M | 5.2%Prev: 3.9% | 229,046 SH | Increased-70,272 SH |
| BRIDGEBIO PHARMA INC | COM | $40.1M | 8.4%Prev: 6.7% | 927,711 SH | Increased+495,697 SH |
| CORCEPT THERAPEUTICS INC | COM | $17.6M | 3.7% | 239,125 SH | New |
| CYTOKINETICS INC | COM NEW | $19.9M | 4.2%Prev: 3.0% | 601,439 SH | Increased+385,938 SH |
| DIANTHUS THERAPEUTICS INC | COM | $13.9M | 2.9%Prev: 9.8% | 746,527 SH | Decreased+186,219 SH |
| DISC MEDICINE INC | COM | $1.6M | 0.3%Prev: 1.6% | 30,661 SH | Decreased-92,317 SH |
| EDWARDS LIFESCIENCES CORP | COM | $30.6M | 6.4%Prev: 2.4% | 390,932 SH | Increased+246,325 SH |
| ELI LILLY & CO | COM | $42.0M | 8.8% | 53,916 SH | New |
| FRACTYL HEALTH INC | COM | $347K | 0.1%Prev: 0.5% | 214,236 SH | Decreased-5,277,630 SH |
| FULCRUM THERAPEUTICS INC | COM | $1.3M | 0.3% | 188,304 SH | New |
| GENEDX HOLDINGS CORP | COM CL A | $5.7M | 1.2% | 61,507 SH | New |
| GILEAD SCIENCES INC | COM | $25.2M | 5.3%Prev: 4.8% | 226,875 SH | Increased+62,970 SH |
| HALOZYME THERAPEUTICS INC | COM | $10.0M | 2.1% | 191,529 SH | New |
| HYPERFINE INC | COM CL A | $547K | 0.1%Prev: 0.3% | 760,035 SH | Decreased-560,006 SH |
| INTUITIVE SURGICAL INC | COM NEW | $30.8M | 6.5% | 56,674 SH | New |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $629K | 0.1%Prev: 1.0% | 146,013 SH | Decreased-751,696 SH |
| KYVERNA THERAPEUTICS INC | COM | $1.8M | 0.4% | 586,909 SH | New |
| MERSANA THERAPEUTICS INC | COM | $464K | 0.1% | 1,567,413 SH | New |
| METAGENOMI INC | COM | $783K | 0.2% | 528,993 SH | New |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $7.7M | 1.6% | 162,596 SH | New |
| NATERA INC | COM | $16.4M | 3.4%Prev: 3.0% | 97,297 SH | Increased+26,390 SH |
| OUTSET MED INC | COM NEW | $3.2M | 0.7%Prev: 0.1% | 166,666 SH | Increased+48,387 SH |
| PHATHOM PHARMACEUTICALS INC | COM | $6.4M | 1.4%Prev: 0.6% | 672,290 SH | Increased+424,523 SH |
| PROTARA THERAPEUTICS INC | COM STK | $4.9M | 1.0%Prev: 0.6% | 1,626,370 SH | Increased+1,046,346 SH |
| REPLIMUNE GROUP INC | COM | $3.1M | 0.6% | 330,337 SH | New |
| SENSEI BIOTHERAPEUTICS INC | COM NEW | $126K | 0.0%Prev: 0.1% | 14,718 SH | Decreased |
| SEPTERNA INC | COM | $3.1M | 0.7%Prev: 1.5% | 294,360 SH | Decreased |
| SOLENO THERAPEUTICS INC | COM | $34.3M | 7.2%Prev: 4.0% | 409,944 SH | Increased-167,864 SH |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $13.9M | 2.9%Prev: 2.6% | 670,575 SH | Increased+415,196 SH |
| SYNDAX PHARMACEUTICALS INC | COM | $19.7M | 4.1%Prev: 5.1% | 2,104,512 SH | Decreased+1,060,842 SH |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | $19.6M | 4.1% | 1,170,372 SH | New |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $7.8M | 1.6%Prev: 3.7% | 213,402 SH | Decreased-637,395 SH |
| UNIQURE NV | SHS | $5.8M | 1.2%Prev: 1.7% | 417,443 SH | Decreased-73,673 SH |
| VIR BIOTECHNOLOGY INC | COM | $2.0M | 0.4% | 388,303 SH | New |
| ZENAS BIOPHARMA INC | COM | $2.1M | 0.4% | 215,314 SH | New |
| 13F-HR |
| 0001958125-26-000005 |
| $532.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001958125-25-000007 | $476.9M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001958125-26-000003 | $478.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001958125-25-000004 | $411.1M | View |